Skip to content

Medical-device intelligence

Abbott Laboratories Inc.: FDA clearances and recalls

Research Abbott Laboratories Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

6 clearance records and 93 recall records in the covered releases, across 1 source company names and 37 product codes. Dated history runs from Dec 29, 2000 to Feb 3, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

99 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity s System software version2.8.0, REF LN 06P16-01, IVD, OEI: (01)00380740138479 The Alinity s System is intended for In Vitro diagnostic u…Z-0749-2022 · MZAAbbott Laboratories, IncRecallMar 11, 2022FDA record creation date
Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donor screening, plasma and plasmapheresi…Z-2276-2021 · MZAAbbott Laboratories, IncRecallAug 12, 2021FDA record creation date
ARCHITECT C System Mixer - Product Usage: The ARCHITECT Clinical Chemistry System is designed to perform automated chemistry tests, utilizing pho…Z-1671-2020 · JJEAbbott Laboratories, IncRecallApr 6, 2020FDA record creation date
APS Accelerator modular systems, 208-230 V-, 50/60 Hz, 1800 VA, IVD, RX, Class 2 Laser Product,Z-2755-2019 · JQPAbbott Laboratories, IncRecallSep 26, 2019FDA record creation date
C3 is an in vitro diagnostic assay for the quantitative determination of C3 in human serum or plasma. Antibodies to C3 combine with C3 in the sam…Z-1987-2019 · CZWAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Immunoglobulin A is an in vitro diagnostic assay for the quantitative determination of immunoglobulin A in human serum or plasma. Antigen in the …Z-1988-2019 · CZPAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Immunoglobulin G is an in vitro diagnostic assay for the quantitative determination of immunoglobulin G in human serum or plasma. Antigen in the …Z-1989-2019 · DEWAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Immunoglobulin M is an in vitro diagnostic assay for the quantitative determination of immunoglobulin M in human serum or plasma. Antigen in the …Z-1990-2019 · DFTAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Apolipoprotein A1 is an in vitro diagnostic assay for the quantitative determination of apolipoprotein A1 in human serum or plasma. Antibodies to…Z-1991-2019 · DERAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
C4 is an in vitro diagnostic assay for the quantitative determination of C4 in human serum or plasma. Antigen in the sample bonds to the specific…Z-1992-2019 · DBIAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
The,K -ASSAY HP assay is intended for the quantitative determination of human haptoglobin by immunoturbidimetric assay. The antiserum used in th…Z-1993-2019 · DADAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Apolipoprotein B is an in vitro diagnostic assay for the quantitative determination of apolipoprotein B in human serum or plasma. Antibodies to a…Z-1994-2019 · DFCAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Transferrin is an in vitro diagnostic assay for the quantitative determination of transferrin in human serum or plasma. Antigen in the sample bo…Z-1995-2019 · DDGAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip Technology) is used for the quant…Z-1296-2019 · CGZAbbott Laboratories, IncRecallMay 8, 2019FDA record creation date
Abbott ARCHITECT c4000 Processing Module, List No. 02P24 - Product Usage: The Abbott ARCHITECT System is intended for In Vitro diagnostic use onl…Z-1102-2019 · JJEAbbott Laboratories, IncRecallApr 8, 2019FDA record creation date
Abbott ARCHITECT c8000 Processing Module, List No. 01G06 - Product Usage: The Abbott ARCHITECT System is intended for In Vitro diagnostic use onl…Z-1103-2019 · JJEAbbott Laboratories, IncRecallApr 8, 2019FDA record creation date
Abbott ARCHITECT c16000 Processing Module, List No. 03L77 - Product Usage: The Abbott ARCHITECT System is intended for In Vitro diagnostic use on…Z-1104-2019 · JJEAbbott Laboratories, IncRecallApr 8, 2019FDA record creation date
Abbott ARCHITECT Creatine Kinase, IVD, REF 7D63-21.Z-1075-2019 · CGSAbbott Laboratories, IncRecallMar 30, 2019FDA record creation date
Abbott ARCHITECT Creatine Kinase, IVD, REF 7D6341.Z-1076-2019 · CGSAbbott Laboratories, IncRecallMar 30, 2019FDA record creation date
ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine…Z-0971-2019 · JGJAbbott Laboratories, IncRecallMar 1, 2019FDA record creation date
CardioMEMS HF System Hospital and Patient Electronics Units: (a) Patient Electronics System, Model CM1100 (b) Hospital Electronics System, Model …Z-2522-2018 · MOMAbbott Laboratories, Inc.RecallJul 20, 2018FDA record creation date
ARCHITECT c4000 Cuvette Segment, Part #02P75-01/02P24, a component to the ARCHITECT Clinical Chemistry system. There are 9 segments with each cu…Z-0921-2018 · JJEAbbott Laboratories, IncRecallJan 18, 2018FDA classification date
ARCHITECT c8000 Cuvette Segment, Part #01G46-01/01G06, a component to the ARCHITECT Clinical Chemistry system. There are 11 segments with each c…Z-0922-2018 · JJEAbbott Laboratories, IncRecallJan 18, 2018FDA classification date
ARCHITECT c16000 Cuvette Segment, Part #09D32-05/ 03L77, a component to the ARCHITECT Clinical Chemistry system. There are 15 segments with each…Z-0923-2018 · JJEAbbott Laboratories, IncRecallJan 18, 2018FDA classification date
ARCHITECT c4000 part number 02P24; ARCHITECT c8000 part number 01G06; ARCHITECT c16000 part number 03L77 Clinical Chemistry systems.Z-0165-2018 · JJEAbbott Laboratories, IncRecallNov 21, 2017FDA record creation date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗